AVCN.TO

Avicanna Inc.

C$0.10

17.65%

SectorHealthcareIndustryDrug Manufacturers - Specialty & GenericCountryCanadaExchangeTSX · CAD

Overview AI Brief ChartChart & Performance Financials ExposureRevenue Exposure FilingsFilings & Red Flags ScoresScores & Valuation News Analysts InsidersInsiders & Short Interest Ownership

Market CapC$13.4M

Dividend Yield0.00%

Beta0.35

AI summary

Price & performance

1M-13.0%

3M-23.1%

YTD-54.5%

1Y-63.0%

52-week range—

Beta0.35

Full chart and returns against a benchmark

Q-Score

36/ 100

Quality against peers; 50 is the peer median.

Growth34

Risk46

Performance33

Valuation48

Profitability51

Leverage23

Sentiment—

Every score and metric

News sentiment

Open News

Latest results · FY 2025

RevenueC$25.5M+0.1%

Net income-C$2.8M

Net margin-11.2%+4.5 pts

Historical fundamentals

Valuation

AVCN.TOIndustryP/E—37.50P/S0.532.82EV/EBITDA—16.62P/B2.922.54PEG—0.74

Dividend yield0.00%

Every valuation metric

Historical Fundamentals

Revenue

Net Income

Net Margin

Showing the last 4 periods. Pro adds the full annual and quarterly history and 20+ more metrics to chart.

Latest Results

The latest fiscal year and quarter, each against the same period a year earlier, from SEC filings.

Metric	FY 2025	vs a year before	Q2 2026	vs a year before
Revenue	C$25.5M	+0.1%	C$5.6M	—
Net Income	-C$2.8M	—	-C$1.3M	—
Net Margin	-11.2%	+4.5 pts	-23.3%	—

Q-Scores

OverallCombines the categories below, except Sentiment

Industry 5836

Growth

Industry 6434

Risk

Industry 6746

Performance

Industry 5833

Valuation

Industry 4948

Profitability

Industry 4951

Leverage

Industry 4523

Key Metrics

Fundamentals: trailing twelve months to Jun 2026, from the latest 10-K and 10-Qs.

Market Beta (5-factor)

IM 0.69SM 0.770.86

Market Cap

9.4M

Dividend Yield

IM 0.00%SM 0.00%0.00%

Volume

IM 606.1KSM 673.8K157K

Industry Market Share

0.00%

Sector Market Share

0.00%

IM industry median · SM sector median: the typical company the value is compared with. The /100 is its score against those peers.

Comparable Companies

The companies closest in size in Drug Manufacturers - Specialty & Generic (filled from its sector when there are few), with the median and rank across all 103 in the industry.

Company	Market cap	P/S	P/B	FCF yield	Implied growth	Revenue growth	Op. margin	ROE	Debt/equity
AVCN.TOAvicanna Inc.	$9.4M	0.5	2.9	-23.8%	—	-0.6%	-14.0%	-83.0%	0.0
BFRIBiofrontera Inc.	$10.4M	0.2	1.7	-76.3%	—	17.8%	-14.2%	-106.9%	0.0
CABRCaring Brands, Inc.	$8.4M	—	—	-26.8%	—	—	—	—	—
UPCUniverse Pharmaceuticals INC	$7.6M	0.0	0.0	—	—	-22.4%	-16.3%	—	0.0
AVNT.TOAvant Brands Inc.	$6.3M	0.2	0.4	52.2%	-16.1%	4.0%	-1.2%	-44.7%	0.6
SNOASonoma Pharmaceuticals, Inc.	$5.5M	0.2	0.8	-50.5%	—	38.7%	-3.3%	-27.2%	0.0
YCBDcbdMD, Inc.	$5M	0.2	0.6	-47.9%	—	10.0%	-13.9%	-35.2%	0.0
AYTUAytu BioPharma, Inc.	$19.3M	0.3	0.5	16.8%	—	-13.3%	-14.4%	-40.4%	0.3
LABS.TOMediPharm Labs Corp.	$19.5M	0.7	0.8	-3.9%	—	-1.2%	-12.3%	-14.0%	0.0
Industry median		1.8	1.6	1.3%	3.3%	8.8%	-5.7%	-14.0%	0.1
AVCN.TO percentile		19th	70th	17th	—	31st	36th	12th	41st